Evidence map›Paper›PMID 40791115›Full record

ArticleKorean journal of ophthalmology : KJO2025

Development of a Hyperopia Animal Model Using Blue Light in Guinea Pigs.

Yung Ju Yoo, Jeong-Min Hwang

Abstract read
In one paragraph

Article in Korean journal of ophthalmology : KJO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yung Ju YooDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.
Jeong-Min HwangDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea.

Funding

Seoul National University Bundang Hospital 02-2020-0005
6 · The paper itself

Abstract

purposeAlthough numerous studies have investigated the progression of myopia, a reliable animal model for hyperopia remains undeveloped. This study aimed to evaluate whether blue light exposure can suppress emmetropization in a manner comparable to lens-induced hyperopia, thereby facilitating the development of an experimental animal model of hyperopia.

methodsFive-day-old 24 guinea pigs were randomly assigned to four different experimental groups based on light exposure conditions. They were housed under a 12-hour light/dark cycle (lights on at 8 AM and off at 8 PM) and exposed to either white light (control) or blue light (460 ± 20 nm). To induce hyperopia, a custom-designed +10 diopters (D) lens was fabricated using a three-dimensional printer and securely attached to randomly selected one eye with hook-and-loop fasteners and tissue adhesive. Refractive errors, corneal curvature, and axial length were measured using streak retinoscopy and A-scan ultrasound, with repeated measurements to assess intereye deviation.

resultsAt the end of the treatment period of 6 weeks, guinea pigs reared under blue light with an attached +10 D lens exhibited a significantly greater hyperopic shift compared to those reared under blue light without the lens. In contrast, guinea pigs raised under white light underwent emmetropization regardless of +10 D lens attachment.

conclusionsBlue light exposure significantly suppressed emmetropization by inducing a marked hyperopic shift in guinea pigs, whereas white light conditions support normal emmetropization regardless of lens attachment. These findings suggest that blue light plays a crucial role in hyperopia induction and can be effectively utilized to establish a stable hyperopia animal model.

Indexed as

Disease Models, AnimalHyperopiaLightRefraction, OcularAnimalsBlue LightGuinea PigsRetinoscopyAxial lengthBlue lightGuinea pigsHyperopia

Identifiers

PMID40791115
PMCPMC12531081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.